← back to search

Karen E. Hoffman

The University of Texas MD Anderson Cancer Center · US
Area of research
Pulmonary and Respiratory Medicine · Radiation
Research interest
Research interests include Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Advanced Radiotherapy Techniques, and Economic and Financial Impacts of Cancer.
h-index
41
citations
6,021
works
221
NIH funding
primary concept
Medicine
email

Recent publications

Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium
The Lancet Oncology 2025cited by 19position: middledoi
Functional Outcomes After Localized Prostate Cancer Treatment
JAMA 2024cited by 86position: middledoi
FORMULA-509: A multicenter randomized trial of post-operative salvage radiotherapy (SRT) and 6 months of GnRH agonist with or without abiraterone acetate/prednisone (AAP) and apalutamide (Apa) post-radical prostatectomy (RP).
Journal of Clinical Oncology 2023cited by 25position: middledoi
Association between Treatment for Localized Prostate Cancer and Mental Health Outcomes.
eScholarship (California Digital Library) 2022cited by 17position: middle
Association of Treatment Modality, Functional Outcomes, and Baseline Characteristics With Treatment-Related Regret Among Men With Localized Prostate Cancer
JAMA Oncology 2021cited by 94position: middledoi
Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer
JAMA 2020cited by 300position: firstdoi
Development and Internal Validation of a Web-based Tool to Predict Sexual, Urinary, and Bowel Function Longitudinally After Radiation Therapy, Surgery, or Observation
European Urology 2020cited by 22position: middledoi
Dose Escalation for Prostate Adenocarcinoma: A Long-Term Update on the Outcomes of a Phase 3, Single Institution Randomized Clinical Trial
International Journal of Radiation Oncology*Biology*Physics 2019cited by 92position: middledoi
Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer
Journal of Clinical Oncology 2018cited by 134position: firstdoi
Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study Results
European Urology 2018cited by 36position: middledoi
Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years
JAMA 2017cited by 345position: middledoi
The Effect of Nerve Sparing Status on Sexual and Urinary Function: 3-Year Results from the CEASAR Study
The Journal of Urology 2017cited by 105position: middledoi
Association of Androgen Deprivation Therapy With Depression in Localized Prostate Cancer
Journal of Clinical Oncology 2016cited by 141position: middledoi
Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study
European Urology 2016cited by 25position: middledoi
Impact of Adherence to Quality Measures for Localized Prostate Cancer on Patient-reported Health-related Quality of Life Outcomes, Patient Satisfaction, and Treatment-related Complications
Medical Care 2016cited by 17position: middledoi
The Comparative Harms of Open and Robotic Prostatectomy in Population Based Samples
The Journal of Urology 2015cited by 64position: middledoi
Association of androgen‐deprivation therapy with excess cardiac‐specific mortality in men with prostate cancer
British Journal of Urology 2014cited by 78position: middledoi
Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment
Cancer 2014cited by 42position: middledoi
Declining use of brachytherapy for the treatment of prostate cancer
Brachytherapy 2013cited by 74position: middledoi
Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study
Journal of Comparative Effectiveness Research 2013cited by 70position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Antoinette M. Stroup · Rutgers, The State University of New Jersey13 papers (2013–2024)Michael Goodman · Emory University13 papers (2013–2024)David F. Penson · Geriatric Research Education and Clinical Center13 papers (2013–2024)Tatsuki Koyama · Vanderbilt University Medical Center13 papers (2013–2024)Daniel A. Barocas · Vanderbilt-Ingram Cancer Center13 papers (2013–2024)Lisa E. Paddock · Rutgers, The State University of New Jersey13 papers (2013–2024)Ann S. Hamilton · University of Southern California13 papers (2013–2024)Matthew R. Cooperberg · UCSF Helen Diller Family Comprehensive Cancer Center11 papers (2013–2022)Ralph Conwill · Vanderbilt University Medical Center9 papers (2015–2024)Mia Hashibe · Huntsman Cancer Institute9 papers (2016–2022)Matthew J. Resnick · Vanderbilt University Medical Center8 papers (2013–2018)Sherrie H. Kaplan · University of California, Irvine8 papers (2013–2022)Xiao‐Cheng Wu · Louisiana State Department of Health and Hospitals7 papers (2015–2020)Li‐Ching Huang · Vanderbilt University Medical Center6 papers (2017–2024)Zhiguo Zhao · Shanghai University of Traditional Chinese Medicine5 papers (2017–2024)Vivien W. Chen · Louisiana State University Health Sciences Center New Orleans5 papers (2013–2018)Xiao‐Cheng Wu · Louisiana State University5 papers (2014–2024)Brock B. O’Neil · University of Utah4 papers (2020–2024) · 3 papers (2015–2017)Steven J. Frank · Hebrew University of Jerusalem3 papers (2013–2019)